Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 931 to 940

ONSETRON ODT 4 ondansetron 4 mg orally disintegrating tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PARACETAMOL AN paracetamol 1000mg/100mL injection solution vial Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROPENN meropenem (as trihydrate) 1 g powder for injection vial Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ROPENN meropenem (as trihydrate) 500 mg powder for injection vial Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ONSETRON 8 ondansetron (as hydrochloride dihydrate) 8 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ONSETRON 4 ondansetron (as hydrochloride dihydrate) 4 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
Suspended from ARTG - RANITIDINE-GA ranitidine 150mg (as hydrochloride) tablet bottle Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRPRESTAN 300 irbesartan 300 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRPRESTAN 150 irbesartan 150 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IRPRESTAN 75 irbesartan 75 mg tablets blister pack Cancelled under Section 30(1)(c) of the Act

16 June 2021

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 90
Page 91
Page 92
Page 93
Current page 94
Page 95
Page 96
Page 97
Page 98
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.